Unique ID issued by UMIN | UMIN000025831 |
---|---|
Receipt number | R000029525 |
Scientific Title | High-dose clarithromycin monotherapy for Helicobacter pylori-negative or -eradicated gastrointestinal MALT lymphomas |
Date of disclosure of the study information | 2017/01/25 |
Last modified on | 2019/03/20 08:24:52 |
High-dose clarithromycin monotherapy for Helicobacter pylori-negative or -eradicated gastrointestinal MALT lymphomas
High-dose CAM monotherapy for MALT lymphomas
High-dose clarithromycin monotherapy for Helicobacter pylori-negative or -eradicated gastrointestinal MALT lymphomas
High-dose CAM monotherapy for MALT lymphomas
Japan |
Gastrointestinal MALT lymphomas
Gastroenterology |
Malignancy
NO
To evaluate the tolerability and efficacy of high-dose clarithromycin (CAM) monotherapy in patients with Helicobacter pylori-negative or eradicated gastrointestinal MALT lymphomas.
Safety,Efficacy
Exploratory
Others
Phase II
Overall response rate (ORR), defined as complete remission (CR) and partial remission (PR).
1) CR rate after 12, 26 and 52 weeks after the start of this therapy.
2) Progression-free survival after 3 years.
3) Adverse events.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Patients were treated with 4 courses of oral administration of clarithromycin (CAM) 2g/day, once daily, days 1-14, every 21 days.
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients with gastrointestinal MALT lymphoma who is negative for H. pylori infection, or who had not achieved CR at least 6 months after H. pylori eradication.
2) Patients with 20 years or older.
3) Written informed consent was obtained.
1) Past history of allergy for CAM.
2) Taking drugs contraindicated for concomitant use with CAM, including calcium-channel blockers.
3) Prolonged QTc, sinus bradycardia (HR <50 bpm), or severe atrioventricular block detected by ECG.
4) Past history of gastrectomy.
5) Combined malignancies other than MALT lymphoma.
6) Severe renal dysfunction (eGFR<30 mL/min/1.73m2).
7) Liver dysfunction
8) Pregnant or possible pregnant women.
9) Others
50
1st name | Shotaro |
Middle name | |
Last name | Nakamura |
Iwate Medical University School of Medicine
Division of Gastroenterology, Department of Internal Medicine
020-8505
Uchimaru 19-1, Morioka 020-8505, Japan
019-651-5111(+2311)
shonaka@iwate-med.ac.jp
1st name | Shotaro |
Middle name | |
Last name | Nakamura |
Iwate Medical University School of Medicine
Division of Gastroenterology, Department of Internal Medicine
020-8505
Uchimaru 19-1, Morioka 020-8505, Japan
019-651-5111(+2311)
shonaka@iwate-med.ac.jp
Iwate Medical University School of Medicine,
Division of Gastroenterology,
Department of Internal Medicine
JAPANGAST Study Group (JGSG)
Other
Japan
Hakodate National Hospita; Okayama University; Hiroshima University; Kyushu University; Hokkaido University; Ibaraki Prefectural Central Hospital; Fukuoka Sanno Hospital
The echics committee at Iwate Medical University Hospital
Uchimaru 19-1, Morioka 020-8505, Japan
019-651-5111(+3111)
hiroaki.kawamori@j.iwate-med.ac.jp
NO
岩手医科大学病院(岩手県)、国立病院機構函館病院(北海道)、岡山大学病院(岡山県)、広島大学病院(広島県)、九州大学病院(福岡県)、北海道大学病院(北海道)、茨城県立中央病院・茨城県地域がんセンター(茨城県)、福岡山王病院(福岡県)
2017 | Year | 01 | Month | 25 | Day |
Unpublished
none
13
Completed
2017 | Year | 01 | Month | 12 | Day |
2017 | Year | 01 | Month | 23 | Day |
2017 | Year | 03 | Month | 16 | Day |
2019 | Year | 03 | Month | 15 | Day |
2019 | Year | 03 | Month | 17 | Day |
2019 | Year | 03 | Month | 17 | Day |
2019 | Year | 03 | Month | 17 | Day |
2017 | Year | 01 | Month | 24 | Day |
2019 | Year | 03 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029525